Low Dose Naltrexone (LDN): The New Breast Cancer Prevention - Global Challenge to Prevent Breast Cancer

6/14/2019; 6 minutes

Laura Markuly works McConnell Air Force Base, owns Bodyology Sports Performance, LLC and is a breast cancer survivor. She presents her bold idea at the Global Challenge to Prevent Breast Cancer -- Using Low Dose Naltrexone (LDN) as a low cost, broad range, new method to prevent breast cancer and cell mutations.
Recorded on 05/15/2019.
(#34870)

Links & Resources

 

SIGN UP FOR EMAIL UPDATES
Subscribe to receive email notifications about featured videos.
(c)2019 Regents of the University of California. All right reserved. Terms and Conditions of Use.